MedTech Outlook Magazine: Specials Magazine

More Lung cancer is being detected at earlier stages than ever before. Low-dose CT screening programs are being introduced worldwide, and this helps physicians identify suspicious lung nodules at stages where many patients are expected to live for years after treatment. That progress is changing the question around intervention. The goal is no longer only to destroy a tumor. It is to treat the disease with enough control to preserve lung function, reduce treatment burden and protect long-term quality of life. Nanotherm Therapeutics is developing its platform around that need. It combines image-guided nanoparticle delivery with external energy delivery to create a more controlled, precise approach to focal tumor treatment. Instead of applying heat through a probe after a target is accessed, Nanotherm’s system allows physicians to first place and verify the treatment material inside the tumor, then activate heat only after coverage has been confirmed. “Technology never sells. What sells is a solution,” says Dr. Andreas Jordan, founder and CEO. “We think we have the solution for early-stage cancer that could significantly expand the treatment options available to many patients.”

Hospitals now stand at the crossroads of rising demand and financial pressure. Reimbursements continue to decline, recruiting and retaining critical staff is increasingly difficult, and patient volumes only go one way—up. Add rising supply costs to the mix, and the margin for error all but disappears. Against this backdrop, Miga Solutions has emerged as a critical ally, helping hospitals tackle one of the few cost centers still ripe for savings: medical equipment. Founded in 2004, Miga began with a simple question: how can the right information unlock the massive savings hidden within hospital medical equipment? “Hospitals have pushed savings in supplies and labor to the limit, but medical, lab, and IT purchases still carry hidden costs,” says Peter Robson, president and CEO. “We enable hospitals to cut through the complexity of the healthcare supply chain with the intelligence to validate pricing and the support to maximize savings, so every dollar goes further in sustaining the care their communities rely on.” For more than a decade, Miga has delivered this clarity through its Equipment Value Management System (EVMS), a SaaS platform leveraging 50,000+ data sources to show hospitals potential savings. Rather than wading through thick reports, hospitals get a simple color-coded rating—red, yellow, or green—indicating whether a price is in line with the market. For staff stretched across extra shifts, having information distilled into a single, clear signal can mean the difference between timely action and costly delay. The company’s stance is that benchmarking alone doesn’t deliver results, but realized savings do. On average, Miga hospital clients see 12 to 16 percent in savings each year, about $30,000 for every bed. It’s money they can point to, not just a line on a report. These savings are achieved without product substitutions or service cuts. Hospitals can put those dollars to work, whether it’s hiring staff, fixing facilities, or strengthening patient care. Miga reinforces this with a guarantee: if annual savings realized with EVMS do not exceed the cost of the subscription, Miga refunds users for the difference. The numbers are best understood in practice. A 400-bed community hospital, working with a $4 million budget for imaging equipment, found itself stalled in negotiations. After long discussions, the supplier’s lowest offer was still $4.8 million. EVMS benchmarking showed that the price could, and should, drop further. Using Miga’s data and advisory support, the hospital reset its negotiations. The contract closed around the $4 million budget, delivering roughly $800,000 in realized savings on the same equipment. For administrators, the win wasn’t only financial, but also the confidence that came with securing the right deal.